AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More
Related Articles
Streamers keep striking out on live TV broadcasts
Posted on Author admin
Apple’s uninspiring Major League Baseball deal reflects linear television’s dominance over live media rights. Read More
Boar-celona! Shakira clashes with purse-snatching hogs as the feral pigs upend European city life
Posted on Author admin
The disease is threatening the world’s largest pig industry. Read More
As the IPO market continues its frenzy, here’s what you need to know
Posted on Author admin
Fortune’s latest Quarterly Investment Guide couldn’t be more timely. Read More